Session 4: State-of-the-Art in Coronary Surgery: What Does the Evidence Say?

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Joseph F. Sabik III, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Consultant/Advisory Board

Jennifer Lawton, MD

Panelists

Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board

Joseph B. Zwischenberger, MD
Disclosure(s): Avalon, Maquet: Royalties; Verthermia Acquisitions, Inc.: Consultant/Advisory Board

Presentations

  1. Atrial Management in the CABG Patient
    Richard Whitlock, MD, PhD, FRCSC
    Disclosure(s): AtriCure – Research Grant, Speakers Bureau/Honoraria; Procyrion – Chair DSMB; Boston Scientific – Research Grant
     
  2. Mechanical Circulatory Support in High-Risk CABG
    Amit Pawale, MD
     
  3. FFR – Why It Matters in PCI, But Not in CABG
    Mario Gaudino, MD, PhD
    Disclosure(s): Abbott Vascular: Consultant/Advisory Board
     
  4. Contemporary Secondary Prevention 
    Subodh Verma, MD, PhD, FRCSC
    Disclosure(s): Amarin, AstraZeneca, Bayer, Boehringer-Ingelheim, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management Inc: Speakers Bureau; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Janssen, Novartis, Novo Nordisk, Sanofi: Consultant/Advisory Board; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi: Other Research Support
Activity summary
Available credit: 
  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit
Activity opens: 
06/12/2025
Activity expires: 
06/30/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Joseph F. Sabik III, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Consultant/Advisory Board

Jennifer Lawton, MD

Panelists

Mario Gaudino, MD, PhD
Disclosure(s): Abbott Vascular: Consultant/Advisory Board

Joseph B. Zwischenberger, MD
Disclosure(s): Avalon, Maquet: Royalties; Verthermia Acquisitions, Inc.: Consultant/Advisory Board

Presentations

  1. Atrial Management in the CABG Patient
    Richard Whitlock, MD, PhD, FRCSC
    Disclosure(s): AtriCure – Research Grant, Speakers Bureau/Honoraria; Procyrion – Chair DSMB; Boston Scientific – Research Grant
     
  2. Mechanical Circulatory Support in High-Risk CABG
    Amit Pawale, MD
     
  3. FFR – Why It Matters in PCI, But Not in CABG
    Mario Gaudino, MD, PhD
    Disclosure(s): Abbott Vascular: Consultant/Advisory Board
     
  4. Contemporary Secondary Prevention 
    Subodh Verma, MD, PhD, FRCSC
    Disclosure(s): Amarin, AstraZeneca, Bayer, Boehringer-Ingelheim, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management Inc: Speakers Bureau; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Janssen, Novartis, Novo Nordisk, Sanofi: Consultant/Advisory Board; Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, HLS Therapeutics, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi: Other Research Support